Skip to content
value.today

Centrexion Corp

🇺🇸 Baltimore, Maryland, USABiotechnologyFounded 2013
Total raised
$136 M
7 rounds on record
Latest round
$3 M
Dec 2023
First round on record
Dec 2016
Today
Private
No later event on record

Funding rounds

7 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Centrexion Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$3 MNo. 7$2 to $10 million

Centrexion Corp: Raise no. 7, Dec 2023

Investors in this round

116 investors had bought by the notice of Jan 8, 2024: 116 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $13 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,283,206
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell, M.D. · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Michael J. Ward · Executive Officer
  • Randall M. Stevens · Executive Officer
  • Colin J. Hill · Director
  • J.C. J. Lopez, M.D. · Director
  • Joseph R. Swedish · Director
  • Shawn R. Tomasello · Director
  • Sol J. Barer, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “The compensation payable to Maxim Group LLC under the total offering amount is estimated to consist of (i) a cash fee (listed above) and (ii) a warrant to purchase up to 855,470 shares of Centrexion's common stock.”

Signed by Michael Ward, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D, newest notice filed Jan 8, 2024. Read the notice at the SEC.

debt, optionsSEC
Nov 2023$2 MNo. 6$2 to $10 million

Centrexion Corp: Raise no. 6, Nov 2023

Investors in this round

2 investors had bought by the notice of Nov 27, 2023: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$230,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell, M.D. · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Michael J. Ward · Executive Officer
  • Randall M. Stevens · Executive Officer
  • Colin J. Hill · Director
  • J.C. J. Lopez, M.D. · Director
  • Joseph R. Swedish · Director
  • Shawn R. Tomasello · Director
  • Sol J. Barer, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • FCC Ltd. · Tel Aviv, IsraelSold in no state named, and outside the US
  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “The aggregate compensation payable to Maxim Group LLC and FCC Ltd. under the total offering amount is estimated to consist of (i) a cash fee (listed above) and (ii) warrants to purchase up to 141,333 shares of Centrexion's common stock.”

Signed by Michael Ward, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D, newest notice filed Nov 27, 2023. Read the notice at the SEC.

debt, optionsSEC
Jun 2023$10 MNo. 5$10 to $50 million

Centrexion Corp: Raise no. 5, Jun 2023

Investors in this round

124 investors had bought by the notice of Jul 11, 2023: 124 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $30 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,972,715
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell, M.D. · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Michael J. Ward · Executive Officer
  • Randall M. Stevens · Executive Officer
  • Colin J. Hill · Director
  • J.C. J. Lopez, M.D. · Director
  • Joseph R. Swedish · Director
  • Shawn R. Tomasello · Director
  • Sol J. Barer, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “The compensation payable to Maxim Group LLC under the total offering amount is estimated to consist of (i) a cash fee (listed above) and (ii) a warrant to purchase up to 1,981,810 shares of Centrexion's common stock.”

Signed by Michael Ward, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jul 11, 2023. Read the notice at the SEC.

debt, optionsSEC
May 2022$29 MNo. 4$10 to $50 million

Centrexion Corp: Raise no. 4, May 2022

Investors in this round

47 investors had bought by the notice of Aug 11, 2022: 47 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$2,622,600
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell, M.D. · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Michael J. Ward · Executive Officer
  • Randall M. Stevens · Executive Officer
  • Colin J. Hill · Director
  • Dezhi J. Kang, Ph.D. · Director
  • J. C. Lopez, M.D. · Director
  • Joseph R. Swedish · Director
  • Peter R. Wirth · Director
  • Shawn R. Tomasello · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “The compensation payable to the finder (Maxim Group LLC) consisted of (i) a cash fee (listed above) plus (ii) the issuance of approximately 475,954 shares of common stock and warrants to purchase up to 1,748,400 shares common stock.”

Signed by Michael Ward, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D and 2 amendments, newest notice filed Aug 11, 2022. Read the notice at the SEC.

debt, optionsSEC
Dec 2017$70 MNo. 3$50 to $250 million

Centrexion Corp: Raise no. 3, Dec 2017

Investors in this round

67 investors had bought by the notice of Jan 2, 2018: 67 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$70 M of $70 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$3,630,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregg J. Beloff · Executive Officer
  • James N. Campbell · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Randall M. Stevens · Executive Officer
  • Arnold Oronsky · Director
  • Isaac J. Blech · Director
  • Sara J. Nayeem · Director
  • Shawn J. Tomasello · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states
  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in CO, MA, MD

Signed by Gregg Beloff, Chief financial officer and treasurer. Source: SEC Form D, newest notice filed Jan 2, 2018. Read the notice at the SEC.

equitySEC
Apr 2017$5 MNo. 2$2 to $10 million

Centrexion Corp: Raise no. 2, Apr 2017

Investors in this round

40 investors had bought by the notice of May 23, 2017: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: Convertible Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$212,450
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer, Director
  • Randall M. Stevens · Executive Officer
  • Arnold Oronsky · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brookline Capital Markets · broker-dealer CIM Securities, LLC (CRD 120852) · New York, New YorkSold in all US states

Signed by Gregg Beloff, Chief Financial Officer. Source: SEC Form D, newest notice filed May 23, 2017. Read the notice at the SEC.

optionsSEC
Dec 2016$17 MNo. 1$10 to $50 million

Centrexion Corp: Raise no. 1, Dec 2016

Investors in this round

14 investors had bought by the notice of Jan 5, 2017: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
$25,000
What was sold
equity, other: Series C Convertible Preferred.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,325,183
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregg L. Beloff · Executive Officer
  • James N. Campbell · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer
  • Kerrie L. Brady · Executive Officer
  • Arnold L. Oronsky · Director
  • Isaac Blech · Director
  • Shengda L. Zan · Director
  • Sol Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC · New York, New YorkSold in all US states

Signed by Gregg Beloff, Authorized Person. Source: SEC Form D, newest notice filed Jan 5, 2017. Read the notice at the SEC.

equitySEC
Nov 2013$9 MIssued in a merger or acquisition$2 to $10 million

Centrexion Corp: Private sale, Nov 2013

Investors in this round

20 investors had bought by the notice of Dec 3, 2013: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A Convertible Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James N. Campbell · Executive Officer, Director
  • Jeffrey B. Kindler · Executive Officer
  • Kerrie L. Brady · Executive Officer
  • Arnold L. Oronsky · Director
  • Isaac Blech · Director
  • Sol Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A Convertible Preferred Stock issued as consideration in a merger transaction and an asset purchase transaction.”
  • On a merger: “5,000,000 shares issued in connection with a merger and an asset purchase.”

Signed by Sol Barer, Authorized Person. Source: SEC Form D and 2 amendments, newest notice filed Dec 3, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Centrexion Corp chose not to state its revenue in its newest notice of a funding round (Jan 2024).

    SEC Form D · Jan 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2024

That is all the official record says: Centrexion Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Centrexion Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 124 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Centrexion Corp
NameRoleNamed in
James N. Campbell, M.D.Executive officerJan 2024
Jeffrey B. KindlerExecutive officerJan 2024
Michael J. WardExecutive officerJan 2024
Randall M. StevensExecutive officerJan 2024
Gregg J. BeloffExecutive officerJan 2018
James N. CampbellExecutive officerJan 2018
Gregg L. BeloffExecutive officerJan 2017
Kerrie L. BradyExecutive officerJan 2017
Colin J. HillDirectorJan 2024
J.C. J. Lopez, M.D.DirectorJan 2024
James N. Campbell, M.D.DirectorJan 2024
Jeffrey B. KindlerDirectorJan 2024
Joseph R. SwedishDirectorJan 2024
Shawn R. TomaselloDirectorJan 2024
Sol J. Barer, Ph.D.DirectorJan 2024
Dezhi J. Kang, Ph.D.DirectorAug 2022
J. C. Lopez, M.D.DirectorAug 2022
Peter R. WirthDirectorAug 2022
Sol J. BarerDirectorAug 2022
Arnold OronskyDirectorJan 2018
Isaac J. BlechDirectorJan 2018
James N. CampbellDirectorJan 2018
Sara J. NayeemDirectorJan 2018
Shawn J. TomaselloDirectorJan 2018
Arnold L. OronskyDirectorJan 2017
Isaac BlechDirectorJan 2017
Shengda L. ZanDirectorJan 2017
Sol BarerDirectorJan 2017